Breast Cancer Trial
Triple-Negative, Including Men
Platinum-Based Chemotherapy or Capecitabine in Treating Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy
Update on March 30, 2021: Study EA1131 is now closed to patient enrollment.
National Cancer Institute: Trial record on cancer.gov
ClinicalTrials.gov Record/ID: NCT02445391
Return to Home Page | Review Other Active Trials